Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy L Weigel

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Molecular Endocrinology (Baltimore, Md.)|May 31, 2007
Steroid receptor phosphorylation: a key modulator of multiple receptor functionsNancy L Weigel, Nicole L Moore
Nuclear Receptor Signaling|May 26, 2007
Kinases and protein phosphorylation as regulators of steroid hormone actionNancy L Weigel, Nicole L Moore
The Prostate|July 15, 2003
Stable expression of full length human androgen receptor in PC-3 prostate cancer cells enhances sensitivity to retinoic acid but not to 1alpha,25-dihydroxyvitamin D3Shalini Murthy, Marco Marcelli, Nancy L Weigel
Endocrinology|January 24, 2009
1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cellsJoyAnn N Phillips Rohan, Nancy L Weigel
Steroids|January 9, 2007
Cyclin dependent kinase 2 and the regulation of human progesterone receptor activityNicole L Moore, Ramesh Narayanan, Nancy L Weigel
Molecular and Cellular Biology|March 31, 2005
Human progesterone receptor displays cell cycle-dependent changes in transcriptional activityRamesh Narayanan, Dean P Edwards, Nancy L Weigel
The International Journal of Biochemistry & Cell Biology|December 29, 2012
Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cellsManjula Nakka, Irina U Agoulnik, Nancy L Weigel
The Prostate|March 9, 2005
Androgen receptor signaling and vitamin D receptor action in prostate cancer cellsShalini Murthy, Irina U Agoulnik, Nancy L Weigel
The Prostate|July 16, 2010
1α,25-dihydroxyvitamin D3 inhibits C4-2 prostate cancer cell growth via a retinoblastoma protein (Rb)-independent G1 arrestMichele N Washington, Jung-Sun Kim, Nancy L Weigel
Steroids|February 6, 2013
Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expressionAyesha A Shafi, Marc B Cox, Nancy L Weigel
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Molecular Endocrinology (Baltimore, Md.)|May 31, 2007
Steroid receptor phosphorylation: a key modulator of multiple receptor functionsNancy L Weigel, Nicole L Moore
Nuclear Receptor Signaling|May 26, 2007
Kinases and protein phosphorylation as regulators of steroid hormone actionNancy L Weigel, Nicole L Moore
The Prostate|July 15, 2003
Stable expression of full length human androgen receptor in PC-3 prostate cancer cells enhances sensitivity to retinoic acid but not to 1alpha,25-dihydroxyvitamin D3Shalini Murthy, Marco Marcelli, Nancy L Weigel
Endocrinology|January 24, 2009
1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cellsJoyAnn N Phillips Rohan, Nancy L Weigel
Steroids|January 9, 2007
Cyclin dependent kinase 2 and the regulation of human progesterone receptor activityNicole L Moore, Ramesh Narayanan, Nancy L Weigel
Molecular and Cellular Biology|March 31, 2005
Human progesterone receptor displays cell cycle-dependent changes in transcriptional activityRamesh Narayanan, Dean P Edwards, Nancy L Weigel
The International Journal of Biochemistry & Cell Biology|December 29, 2012
Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cellsManjula Nakka, Irina U Agoulnik, Nancy L Weigel
The Prostate|March 9, 2005
Androgen receptor signaling and vitamin D receptor action in prostate cancer cellsShalini Murthy, Irina U Agoulnik, Nancy L Weigel
The Prostate|July 16, 2010
1α,25-dihydroxyvitamin D3 inhibits C4-2 prostate cancer cell growth via a retinoblastoma protein (Rb)-independent G1 arrestMichele N Washington, Jung-Sun Kim, Nancy L Weigel
Steroids|February 6, 2013
Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expressionAyesha A Shafi, Marc B Cox, Nancy L Weigel
Pageof 8